57 related articles for article (PubMed ID: 3884966)
1. Instability of fasting blood glucose values in noninsulin-dependent diabetic patients with long-term insulin treatment.
Hsieh SD; Akanuma Y
Metabolism; 1985 Apr; 34(4):371-6. PubMed ID: 3884966
[TBL] [Abstract][Full Text] [Related]
2. Reduction of C-peptide secretion in noninsulin-dependent diabetic patients with long duration of insulin treatment.
Hsieh SD; Akanuma Y; Kawazu S; Mashiko S; Kanazawa Y; Iwamoto Y; Kikuchi M; Kosaka K
Endocrinol Jpn; 1983 Jun; 30(3):373-80. PubMed ID: 6363048
[TBL] [Abstract][Full Text] [Related]
3. A study of serum free C-peptide responses to oral glucose load in diabetic patients: with special reference to types of diabetes and methods of treatment.
Hsieh SD; Akanuma Y; Takaku F
Tohoku J Exp Med; 1984 Mar; 142(3):249-60. PubMed ID: 6374968
[TBL] [Abstract][Full Text] [Related]
4. Serum free C-peptide response to oral glucose loading as a parameter for the monitoring of pancreatic B-cell function in diabetic patients.
Hsieh SD; Kanazawa Y; Akanuma Y
Diabetes Res Clin Pract; 1985 Aug; 1(2):109-14. PubMed ID: 3915258
[TBL] [Abstract][Full Text] [Related]
5. C-peptide response to glucagon in type 2 diabetes mellitus: a comparison with oral glucose tolerance test.
Iwasaki Y; Kondo K; Hasegawa H; Oiso Y
Diabetes Res; 1994; 25(3):129-37. PubMed ID: 7671552
[TBL] [Abstract][Full Text] [Related]
6. Insulin response to oral glucose load is consistently decreased in established non-insulin-dependent diabetes mellitus: the usefulness of decreased early insulin response as a predictor of non-insulin-dependent diabetes mellitus.
Kosaka K; Kuzuya T; Hagura R; Yoshinaga H
Diabet Med; 1996 Sep; 13(9 Suppl 6):S109-19. PubMed ID: 8894494
[TBL] [Abstract][Full Text] [Related]
7. Non-insulin-dependent diabetes: 10-year outcome in relation to initial response to diet and subsequent sulfonylurea therapy.
Sönksen PH; Lowy C; Perkins JR; Lim HS
Diabetes Care; 1984; 7 Suppl 1():59-66. PubMed ID: 6376030
[TBL] [Abstract][Full Text] [Related]
8. Increased complications in noninsulin-dependent diabetic patients treated with insulin versus oral hypoglycemic agents: a population study.
Savage S; Estacio RO; Jeffers B; Schrier RW
Proc Assoc Am Physicians; 1997 Mar; 109(2):181-9. PubMed ID: 9069587
[TBL] [Abstract][Full Text] [Related]
9. Glucose tolerance and insulin response to glucose load before and after enzyme inducing therapy in subjects with glucose intolerance and patients with NIDDM having hyperinsulinemia or relative insulin deficiency.
Sotaniemi EA; Karvonen I
Diabetes Res; 1989 Jul; 11(3):131-9. PubMed ID: 2697484
[TBL] [Abstract][Full Text] [Related]
10. Assisting effects of lithium on hypoglycemic treatment in patients with diabetes.
Hu M; Wu H; Chao C
Biol Trace Elem Res; 1997; 60(1-2):131-7. PubMed ID: 9404682
[TBL] [Abstract][Full Text] [Related]
11. Disproportionately elevated proinsulin in Pima Indians with noninsulin-dependent diabetes mellitus.
Saad MF; Kahn SE; Nelson RG; Pettitt DJ; Knowler WC; Schwartz MW; Kowalyk S; Bennett PH; Porte D
J Clin Endocrinol Metab; 1990 May; 70(5):1247-53. PubMed ID: 2186054
[TBL] [Abstract][Full Text] [Related]
12. Long-term instability of fasting plasma glucose predicts mortality in elderly NIDDM patients: the Verona Diabetes Study.
Muggeo M; Verlato G; Bonora E; Ciani F; Moghetti P; Eastman R; Crepaldi G; de Marco R
Diabetologia; 1995 Jun; 38(6):672-9. PubMed ID: 7672488
[TBL] [Abstract][Full Text] [Related]
13. Diurnal variation of blood ketone bodies in insulin-dependent diabetes mellitus and noninsulin-dependent diabetes mellitus patients: the relationship to serum C-peptide immunoreactivity and free insulin.
Ubukata E
Ann Nutr Metab; 1990; 34(6):333-42. PubMed ID: 2076025
[TBL] [Abstract][Full Text] [Related]
14. Circadian variations in plasma immunoreactive insulin (IRI) and C-peptide concentrations in adult onset (type II) diabetes mellitus.
Nicolau GY; Haus E; Lakatua DJ; Bogdan C; Petrescu E; Sackett-Lundeen L; Stelea S; Stelea P
Endocrinologie; 1984; 22(1):3-16. PubMed ID: 6369501
[TBL] [Abstract][Full Text] [Related]
15. Insulin versus glipizide treatment in patients with non-insulin-dependent diabetes mellitus. Effects on blood pressure and glucose tolerance.
Levy J; Vandenberg M; Grunberger G
Am J Hypertens; 1995 May; 8(5 Pt 1):445-53. PubMed ID: 7662219
[TBL] [Abstract][Full Text] [Related]
16. Long-term glycemic control relates to mortality in type II diabetes.
Andersson DK; Svärdsudd K
Diabetes Care; 1995 Dec; 18(12):1534-43. PubMed ID: 8722048
[TBL] [Abstract][Full Text] [Related]
17. The effects of metformin on body mass index and glucose tolerance in obese adolescents with fasting hyperinsulinemia and a family history of type 2 diabetes.
Freemark M; Bursey D
Pediatrics; 2001 Apr; 107(4):E55. PubMed ID: 11335776
[TBL] [Abstract][Full Text] [Related]
18. Earlier appearance of impaired insulin secretion than of visceral adiposity in the pathogenesis of NIDDM. 5-Year follow-up of initially nondiabetic Japanese-American men.
Chen KW; Boyko EJ; Bergstrom RW; Leonetti DL; Newell-Morris L; Wahl PW; Fujimoto WY
Diabetes Care; 1995 Jun; 18(6):747-53. PubMed ID: 7555498
[TBL] [Abstract][Full Text] [Related]
19. Metabolic effects of new oral hypoglycemic agent CS-045 in NIDDM subjects.
Suter SL; Nolan JJ; Wallace P; Gumbiner B; Olefsky JM
Diabetes Care; 1992 Feb; 15(2):193-203. PubMed ID: 1547676
[TBL] [Abstract][Full Text] [Related]
20. Follow-up of women with previous GDM. Insulin, C-peptide, and proinsulin responses to oral glucose load.
Persson B; Hanson U; Hartling SG; Binder C
Diabetes; 1991 Dec; 40 Suppl 2():136-41. PubMed ID: 1748243
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
